Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)
Ptc Therapeutics has reported Current Taxes over the past 7 years, most recently at $4.7 million for Q4 2025.
- Quarterly results put Current Taxes at $4.7 million for Q4 2025, down 0.51% from a year ago — trailing twelve months through Dec 2025 was $4.7 million (down 0.51% YoY), and the annual figure for FY2025 was $4.7 million, down 0.51%.
- Current Taxes for Q4 2025 was $4.7 million at Ptc Therapeutics, up from $2.9 million in the prior quarter.
- Over the last five years, Current Taxes for PTCT hit a ceiling of $64.6 million in Q1 2025 and a floor of $618000.0 in Q2 2021.
- Median Current Taxes over the past 5 years was $4.7 million (2025), compared with a mean of $10.0 million.
- Biggest five-year swings in Current Taxes: plummeted 70.17% in 2021 and later surged 3425.48% in 2025.
- Ptc Therapeutics' Current Taxes stood at $1.3 million in 2021, then surged by 266.12% to $4.7 million in 2022, then plummeted by 40.11% to $2.8 million in 2023, then soared by 66.58% to $4.7 million in 2024, then dropped by 0.51% to $4.7 million in 2025.
- The last three reported values for Current Taxes were $4.7 million (Q4 2025), $2.9 million (Q3 2025), and $39.9 million (Q2 2025) per Business Quant data.